logo

1.89

1.89 (-3.28%)

As of Mar 06, 2024

Proqr Therapeutics N.V. [PRQR]

Source: 

Company Overview

To date, we have financed our operations primarily through our initial public and follow-on offerings, our ATM facility and private placements of equity securities, convertible loans, licensing and research collaborations and to a lesser extent through funding from governmental bodies and patient organizations, Foundation Fighting Blindness (FFB) and Netherlands Enterprise Agency (RVO).

CountryNetherlands
Headquartersleiden
Phone Number31 88 166 7000
Industry
manufacturing
CEODaniel De Boer
WebsiteProQR.com